KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $15,158,000 | +53.6% | 84,300 | -11.4% | 0.01% | +37.5% |
| Q2 2017 | $9,869,000 | +113.8% | 95,200 | +61.9% | 0.01% | +100.0% |
| Q1 2017 | $4,615,000 | +67.6% | 58,800 | -4.2% | 0.00% | +100.0% |
| Q4 2016 | $2,753,000 | -19.7% | 61,400 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $3,430,000 | +11.7% | 61,400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,070,000 | +28.4% | 61,400 | +17.9% | 0.00% | +50.0% |
| Q1 2016 | $2,391,000 | -22.1% | 52,074 | +4.6% | 0.00% | -33.3% |
| Q4 2015 | $3,069,000 | +11.1% | 49,800 | +0.4% | 0.00% | +50.0% |
| Q3 2015 | $2,762,000 | -8.8% | 49,600 | -0.1% | 0.00% | -33.3% |
| Q2 2015 | $3,027,000 | +311.8% | 49,650 | +289.4% | 0.00% | +200.0% |
| Q1 2015 | $735,000 | +29.4% | 12,750 | +29.4% | 0.00% | – |
| Q4 2014 | $568,000 | – | 9,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|